Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
R2 Technology was a pioneering medical technology company specializing in computer-aided detection (CAD) for the early discovery of cancer. The company is best known for developing the ImageChecker system, which became the first CAD software to receive FDA approval for use in screening mammography. This technology assists radiologists by highlighting suspicious areas on mammograms and chest X-rays that may warrant further review. In 2006, R2 Technology was acquired by Hologic, a major provider of diagnostic and surgical products for women's health. Today, its legacy CAD algorithms remain a core component of Hologic's breast health imaging portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on R2 Technology.